Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 20 (1), 561

Leucine-enriched Essential Amino Acid Supplementation in Mechanically Ventilated Trauma Patients: A Feasibility Study

Randomized Controlled Trial

Leucine-enriched Essential Amino Acid Supplementation in Mechanically Ventilated Trauma Patients: A Feasibility Study

L Wandrag et al. Trials.


Background: Critically ill patients lose up to 2% of muscle mass per day. We assessed the feasibility of administering a leucine-enriched essential amino acid (L-EAA) supplement to mechanically ventilated trauma patients with the aim of assessing the effect on skeletal muscle mass and function.

Methods: A randomised feasibility study was performed over six months in intensive care (ICU). Patients received 5 g L-EAA five times per day in addition to standard feed (L-EAA group) or standard feed only (control group) for up to 14 days. C-reactive protein, albumin, IL-6, IL-10, urinary 3-MH, nitrogen balance, protein turnover ([1-13C] leucine infusion), muscle depth change (ultrasound), functional change (Katz and Barthel indices) and muscle strength Medical Research Council (MRC) sum score to assess ICU Acquired Weakness were measured sequentially.

Results: Eight patients (9.5% of screened patients) were recruited over six months. L-EAA doses were provided on 91/124 (73%) occasions. Inflammatory and urinary marker data were collected; serial muscle depth measurements were lacking due to short length of stay. Protein turnover studies were performed on five occasions. MRC sum score could not be performed as patients were not able to respond to the screening questions. The Katz and Barthel indices did not change. L-EAA delivery was achievable, but meaningful functional and muscle mass outcome measures require careful consideration in the design of a future randomised controlled trial.

Conclusion: L-EAA was practical to provide, but we found significant barriers to recruitment and measurement of the chosen outcomes which would need to be addressed in the design of a future, large randomised controlled trial.

Trial registration: ISRCTN Registry, ISRCTN79066838 . Registered on 25 July 2012.

Keywords: Critically ill; Essential amino acids; Leucine; Mechanical ventilation; Muscle ultrasound; Muscle wasting; Nitrogen balance; Protein turnover; Trauma.

Conflict of interest statement

The authors declare that they have no competing interests.


Fig. 1
Fig. 1
Patient recruitment for the feasibility study. CCF: congestive cardiac failure; EN: enteral nutrition; ICU: intensive Care Unit; L-EAA leucine-enriched essential amino acid, NGT nasogastric tube, NOK next-of-kin. No research staff --> no reserach staff for recruitment and enrolment; recent ICU admission- other hospital; re-admission - same hospital ICU

Similar articles

See all similar articles


    1. Puthucheary ZA, McPhail MJ, Hart N. Acute muscle wasting among critically ill patients--reply. JAMA. 2014;311(6):622–623. doi: 10.1001/jama.2013.285426. - DOI - PubMed
    1. Reid CL, Campbell IT, Little RA. Muscle wasting and energy balance in critical illness. Clin Nutr. 2004;23(2):273–280. doi: 10.1016/S0261-5614(03)00129-8. - DOI - PubMed
    1. Herridge MS. The challenge of designing a post-critical illness rehabilitation intervention. Crit Care. 2011;15(5):1002. doi: 10.1186/cc10362. - DOI - PMC - PubMed
    1. Rondanelli M, Opizzi A, Antoniello N, Boschi F, Iadarola P, Pasini E, et al. Effect of essential amino acid supplementation on quality of life, amino acid profile and strength in institutionalized elderly patients. Clin Nutr. 2011;30(5):571–577. doi: 10.1016/j.clnu.2011.04.005. - DOI - PubMed
    1. Anthony JC, Anthony TG, Kimball SR, Jefferson LS. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr. 2001;131(3):856S–860S. doi: 10.1093/jn/131.3.856S. - DOI - PubMed

Publication types